List Alan's most recent trade in TuHURA Biosciences Inc. was a trade of 51,275 Options (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TuHURA Biosciences Inc. | Alan List | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 51,275 | 51,275 | - | - | Options (Right to Buy) | |
TuHURA Biosciences Inc. | Alan List | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 13,553 | 13,553 | - | - | Options (Right to Buy) | |
TuHURA Biosciences Inc. | Alan List | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 13,553 | 13,553 | - | - | Options (Right to Buy) | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 982 | 981 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 982 | 4,778 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.32 per share. | 01 May 2024 | 290 | 4,488 (0%) | 0% | 10.3 | 2,993 | Common Stock |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2024 | 868 | 4,034 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2024 | 868 | 0 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 26 Apr 2024 | 238 | 3,796 (0%) | 0% | 10.0 | 2,386 | Common Stock |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2024 | 60,012 | 116,508 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | List Alan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2024 | 60,012 | 119,988 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.36 per share. | 20 Jan 2024 | 21,526 | 94,982 (0%) | 0% | 0.4 | 7,749 | Common Stock |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 26,027 | 26,028 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 26,027 | 64,267 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 26 Apr 2023 | 7,771 | 56,496 (0%) | 0% | 0.8 | 6,139 | Common Stock |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 29,453 | 47,713 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 29,453 | 58,890 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.07 per share. | 03 Mar 2023 | 9,473 | 38,240 (0%) | 0% | 1.1 | 10,136 | Common Stock |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 180,000 | 180,000 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2022 | 26,035 | 26,035 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2022 | 26,035 | 52,055 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.10 per share. | 26 Apr 2022 | 7,775 | 18,260 (0%) | 0% | 2.1 | 16,328 | Common Stock |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 140,299 | 140,299 | - | - | Employee Stock Option (Right to Buy) | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 88,343 | 88,343 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 134,186 | 134,186 | - | - | Employee Stock Option (Right to Buy) | |
Precision Biosciences Inc | Alan List | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 78,090 | 78,090 | - | - | Restricted Stock Units |